RecruitingNot ApplicableNCT06958848

16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

Comparison of 16F Versus 24F Chest Drain After Minimally Invasive Pulmonary Lobectomy and/or Segmentectomy: a Monocentre Prospective Randomized Controlled Trial


Sponsor

University Hospital, Basel, Switzerland

Enrollment

124 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called 16 F chest tube, a medical device called 24 F chest tube, and others for people with pleural effusion and pneumothorax. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE16 F chest tube

Insertion of 16F chest tube

DEVICE24 F chest tube

Insertion of 24F chest tube

PROCEDUREEarly removal

Removal 2-6h after end of skin closure

PROCEDUREStandard removal

Removal 1day postoperative


Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06958848


Related Trials